Users have reported improved energy levels, clearer skin, and better overall well-being after regular use
Approved in 2022 for diabetes (brand Mounjaro), tirzepatide produced extraordinary results in weight loss up to ~22% in obese participants at the highest dose in a phase 3 trial ( [137] )
DOI:10.1186/1743-7075-9-35 [ Links ] 14
European Journal of Nutrition, 54 (2), 251263.
Commonly reported side effects of sermorelin include injection site reactions, which may include: Pain Swelling Bleeding Inflammation Induration Further, one 16-week trial reported transient hyperlipidemia in a patient receiving sermorelin [15]
It is presumably regulated by intracellular Ca 2+ concentrations, its phosphorylation state and the binding of various activators